biotech semaglutide JPMorgan is getting in on the Ozempic craze with a $500 million fund Why buying weight loss drugs

Description

Neumann et al

This mechanism is particularly relevant for people with polycystic ovary syndrome (PCOS), a condition characterised by insulin resistance, hyperandrogenism, and often troublesome acne

Initially approved for managing type 2 diabetes in humans, Semaglutide has shown remarkable efficacy in weight management, which has led to its exploration for veterinary use

These reductions in HbA1c levels were accompanied by notable weight loss, with changes from 1.9 kg in the study by Ahrn et al

The recent dip in obesity rates is potentially due to GLP-1s The correlation between the recent dip in obesity prevalence rates and the use of GLP-1s and associated lifestyle modifications is likely no coincidence